Global Gene-based Therapy Medicinal Market Research Report 2024(Status and Outlook)
Report Overview:
Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The Global Gene-based Therapy Medicinal Market Size was estimated at USD 2269.80 million in 2023 and is projected to reach USD 9082.63 million by 2029, exhibiting a CAGR of 26.00% during the forecast period.
This report provides a deep insight into the global Gene-based Therapy Medicinal market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gene-based Therapy Medicinal Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gene-based Therapy Medicinal market in any manner.
Global Gene-based Therapy Medicinal Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Market Segmentation (by Type)
Viral Gene Delivery System
Non-viral Gene Delivery System
Market Segmentation (by Application)
Neurological Diseases
Cancer
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gene-based Therapy Medicinal Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The Global Gene-based Therapy Medicinal Market Size was estimated at USD 2269.80 million in 2023 and is projected to reach USD 9082.63 million by 2029, exhibiting a CAGR of 26.00% during the forecast period.
This report provides a deep insight into the global Gene-based Therapy Medicinal market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gene-based Therapy Medicinal Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gene-based Therapy Medicinal market in any manner.
Global Gene-based Therapy Medicinal Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Market Segmentation (by Type)
Viral Gene Delivery System
Non-viral Gene Delivery System
Market Segmentation (by Application)
Neurological Diseases
Cancer
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Gene-based Therapy Medicinal Market
- Overview of the regional outlook of the Gene-based Therapy Medicinal Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gene-based Therapy Medicinal Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Gene-based Therapy Medicinal
1.2 Key Market Segments
1.2.1 Gene-based Therapy Medicinal Segment by Type
1.2.2 Gene-based Therapy Medicinal Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GENE-BASED THERAPY MEDICINAL MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gene-based Therapy Medicinal Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Gene-based Therapy Medicinal Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GENE-BASED THERAPY MEDICINAL MARKET COMPETITIVE LANDSCAPE
3.1 Global Gene-based Therapy Medicinal Sales by Manufacturers (2019-2024)
3.2 Global Gene-based Therapy Medicinal Revenue Market Share by Manufacturers (2019-2024)
3.3 Gene-based Therapy Medicinal Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gene-based Therapy Medicinal Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Gene-based Therapy Medicinal Sales Sites, Area Served, Product Type
3.6 Gene-based Therapy Medicinal Market Competitive Situation and Trends
3.6.1 Gene-based Therapy Medicinal Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gene-based Therapy Medicinal Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GENE-BASED THERAPY MEDICINAL INDUSTRY CHAIN ANALYSIS
4.1 Gene-based Therapy Medicinal Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GENE-BASED THERAPY MEDICINAL MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GENE-BASED THERAPY MEDICINAL MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gene-based Therapy Medicinal Sales Market Share by Type (2019-2024)
6.3 Global Gene-based Therapy Medicinal Market Size Market Share by Type (2019-2024)
6.4 Global Gene-based Therapy Medicinal Price by Type (2019-2024)
7 GENE-BASED THERAPY MEDICINAL MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gene-based Therapy Medicinal Market Sales by Application (2019-2024)
7.3 Global Gene-based Therapy Medicinal Market Size (M USD) by Application (2019-2024)
7.4 Global Gene-based Therapy Medicinal Sales Growth Rate by Application (2019-2024)
8 GENE-BASED THERAPY MEDICINAL MARKET SEGMENTATION BY REGION
8.1 Global Gene-based Therapy Medicinal Sales by Region
8.1.1 Global Gene-based Therapy Medicinal Sales by Region
8.1.2 Global Gene-based Therapy Medicinal Sales Market Share by Region
8.2 North America
8.2.1 North America Gene-based Therapy Medicinal Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gene-based Therapy Medicinal Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Gene-based Therapy Medicinal Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gene-based Therapy Medicinal Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gene-based Therapy Medicinal Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Biogen
9.1.1 Biogen Gene-based Therapy Medicinal Basic Information
9.1.2 Biogen Gene-based Therapy Medicinal Product Overview
9.1.3 Biogen Gene-based Therapy Medicinal Product Market Performance
9.1.4 Biogen Business Overview
9.1.5 Biogen Gene-based Therapy Medicinal SWOT Analysis
9.1.6 Biogen Recent Developments
9.2 Novartis
9.2.1 Novartis Gene-based Therapy Medicinal Basic Information
9.2.2 Novartis Gene-based Therapy Medicinal Product Overview
9.2.3 Novartis Gene-based Therapy Medicinal Product Market Performance
9.2.4 Novartis Business Overview
9.2.5 Novartis Gene-based Therapy Medicinal SWOT Analysis
9.2.6 Novartis Recent Developments
9.3 Gilead Sciences
9.3.1 Gilead Sciences Gene-based Therapy Medicinal Basic Information
9.3.2 Gilead Sciences Gene-based Therapy Medicinal Product Overview
9.3.3 Gilead Sciences Gene-based Therapy Medicinal Product Market Performance
9.3.4 Gilead Sciences Gene-based Therapy Medicinal SWOT Analysis
9.3.5 Gilead Sciences Business Overview
9.3.6 Gilead Sciences Recent Developments
9.4 Sarepta Therapeutics
9.4.1 Sarepta Therapeutics Gene-based Therapy Medicinal Basic Information
9.4.2 Sarepta Therapeutics Gene-based Therapy Medicinal Product Overview
9.4.3 Sarepta Therapeutics Gene-based Therapy Medicinal Product Market Performance
9.4.4 Sarepta Therapeutics Business Overview
9.4.5 Sarepta Therapeutics Recent Developments
9.5 Alnylam Pharmaceuticals
9.5.1 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Basic Information
9.5.2 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Product Overview
9.5.3 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Product Market Performance
9.5.4 Alnylam Pharmaceuticals Business Overview
9.5.5 Alnylam Pharmaceuticals Recent Developments
9.6 Amgen
9.6.1 Amgen Gene-based Therapy Medicinal Basic Information
9.6.2 Amgen Gene-based Therapy Medicinal Product Overview
9.6.3 Amgen Gene-based Therapy Medicinal Product Market Performance
9.6.4 Amgen Business Overview
9.6.5 Amgen Recent Developments
9.7 Spark Therapeutics
9.7.1 Spark Therapeutics Gene-based Therapy Medicinal Basic Information
9.7.2 Spark Therapeutics Gene-based Therapy Medicinal Product Overview
9.7.3 Spark Therapeutics Gene-based Therapy Medicinal Product Market Performance
9.7.4 Spark Therapeutics Business Overview
9.7.5 Spark Therapeutics Recent Developments
9.8 Akcea Therapeutics
9.8.1 Akcea Therapeutics Gene-based Therapy Medicinal Basic Information
9.8.2 Akcea Therapeutics Gene-based Therapy Medicinal Product Overview
9.8.3 Akcea Therapeutics Gene-based Therapy Medicinal Product Market Performance
9.8.4 Akcea Therapeutics Business Overview
9.8.5 Akcea Therapeutics Recent Developments
9.9 Sunway Biotech
9.9.1 Sunway Biotech Gene-based Therapy Medicinal Basic Information
9.9.2 Sunway Biotech Gene-based Therapy Medicinal Product Overview
9.9.3 Sunway Biotech Gene-based Therapy Medicinal Product Market Performance
9.9.4 Sunway Biotech Business Overview
9.9.5 Sunway Biotech Recent Developments
9.10 SIBIONO
9.10.1 SIBIONO Gene-based Therapy Medicinal Basic Information
9.10.2 SIBIONO Gene-based Therapy Medicinal Product Overview
9.10.3 SIBIONO Gene-based Therapy Medicinal Product Market Performance
9.10.4 SIBIONO Business Overview
9.10.5 SIBIONO Recent Developments
9.11 AnGes
9.11.1 AnGes Gene-based Therapy Medicinal Basic Information
9.11.2 AnGes Gene-based Therapy Medicinal Product Overview
9.11.3 AnGes Gene-based Therapy Medicinal Product Market Performance
9.11.4 AnGes Business Overview
9.11.5 AnGes Recent Developments
9.12 Orchard Therapeutics
9.12.1 Orchard Therapeutics Gene-based Therapy Medicinal Basic Information
9.12.2 Orchard Therapeutics Gene-based Therapy Medicinal Product Overview
9.12.3 Orchard Therapeutics Gene-based Therapy Medicinal Product Market Performance
9.12.4 Orchard Therapeutics Business Overview
9.12.5 Orchard Therapeutics Recent Developments
9.13 Human Stem Cells Institute
9.13.1 Human Stem Cells Institute Gene-based Therapy Medicinal Basic Information
9.13.2 Human Stem Cells Institute Gene-based Therapy Medicinal Product Overview
9.13.3 Human Stem Cells Institute Gene-based Therapy Medicinal Product Market Performance
9.13.4 Human Stem Cells Institute Business Overview
9.13.5 Human Stem Cells Institute Recent Developments
10 GENE-BASED THERAPY MEDICINAL MARKET FORECAST BY REGION
10.1 Global Gene-based Therapy Medicinal Market Size Forecast
10.2 Global Gene-based Therapy Medicinal Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Gene-based Therapy Medicinal Market Size Forecast by Country
10.2.3 Asia Pacific Gene-based Therapy Medicinal Market Size Forecast by Region
10.2.4 South America Gene-based Therapy Medicinal Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Gene-based Therapy Medicinal by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Gene-based Therapy Medicinal Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Gene-based Therapy Medicinal by Type (2025-2030)
11.1.2 Global Gene-based Therapy Medicinal Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Gene-based Therapy Medicinal by Type (2025-2030)
11.2 Global Gene-based Therapy Medicinal Market Forecast by Application (2025-2030)
11.2.1 Global Gene-based Therapy Medicinal Sales (Kilotons) Forecast by Application
11.2.2 Global Gene-based Therapy Medicinal Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Gene-based Therapy Medicinal
1.2 Key Market Segments
1.2.1 Gene-based Therapy Medicinal Segment by Type
1.2.2 Gene-based Therapy Medicinal Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GENE-BASED THERAPY MEDICINAL MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gene-based Therapy Medicinal Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Gene-based Therapy Medicinal Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GENE-BASED THERAPY MEDICINAL MARKET COMPETITIVE LANDSCAPE
3.1 Global Gene-based Therapy Medicinal Sales by Manufacturers (2019-2024)
3.2 Global Gene-based Therapy Medicinal Revenue Market Share by Manufacturers (2019-2024)
3.3 Gene-based Therapy Medicinal Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gene-based Therapy Medicinal Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Gene-based Therapy Medicinal Sales Sites, Area Served, Product Type
3.6 Gene-based Therapy Medicinal Market Competitive Situation and Trends
3.6.1 Gene-based Therapy Medicinal Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gene-based Therapy Medicinal Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GENE-BASED THERAPY MEDICINAL INDUSTRY CHAIN ANALYSIS
4.1 Gene-based Therapy Medicinal Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GENE-BASED THERAPY MEDICINAL MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GENE-BASED THERAPY MEDICINAL MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gene-based Therapy Medicinal Sales Market Share by Type (2019-2024)
6.3 Global Gene-based Therapy Medicinal Market Size Market Share by Type (2019-2024)
6.4 Global Gene-based Therapy Medicinal Price by Type (2019-2024)
7 GENE-BASED THERAPY MEDICINAL MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gene-based Therapy Medicinal Market Sales by Application (2019-2024)
7.3 Global Gene-based Therapy Medicinal Market Size (M USD) by Application (2019-2024)
7.4 Global Gene-based Therapy Medicinal Sales Growth Rate by Application (2019-2024)
8 GENE-BASED THERAPY MEDICINAL MARKET SEGMENTATION BY REGION
8.1 Global Gene-based Therapy Medicinal Sales by Region
8.1.1 Global Gene-based Therapy Medicinal Sales by Region
8.1.2 Global Gene-based Therapy Medicinal Sales Market Share by Region
8.2 North America
8.2.1 North America Gene-based Therapy Medicinal Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gene-based Therapy Medicinal Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Gene-based Therapy Medicinal Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gene-based Therapy Medicinal Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gene-based Therapy Medicinal Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Biogen
9.1.1 Biogen Gene-based Therapy Medicinal Basic Information
9.1.2 Biogen Gene-based Therapy Medicinal Product Overview
9.1.3 Biogen Gene-based Therapy Medicinal Product Market Performance
9.1.4 Biogen Business Overview
9.1.5 Biogen Gene-based Therapy Medicinal SWOT Analysis
9.1.6 Biogen Recent Developments
9.2 Novartis
9.2.1 Novartis Gene-based Therapy Medicinal Basic Information
9.2.2 Novartis Gene-based Therapy Medicinal Product Overview
9.2.3 Novartis Gene-based Therapy Medicinal Product Market Performance
9.2.4 Novartis Business Overview
9.2.5 Novartis Gene-based Therapy Medicinal SWOT Analysis
9.2.6 Novartis Recent Developments
9.3 Gilead Sciences
9.3.1 Gilead Sciences Gene-based Therapy Medicinal Basic Information
9.3.2 Gilead Sciences Gene-based Therapy Medicinal Product Overview
9.3.3 Gilead Sciences Gene-based Therapy Medicinal Product Market Performance
9.3.4 Gilead Sciences Gene-based Therapy Medicinal SWOT Analysis
9.3.5 Gilead Sciences Business Overview
9.3.6 Gilead Sciences Recent Developments
9.4 Sarepta Therapeutics
9.4.1 Sarepta Therapeutics Gene-based Therapy Medicinal Basic Information
9.4.2 Sarepta Therapeutics Gene-based Therapy Medicinal Product Overview
9.4.3 Sarepta Therapeutics Gene-based Therapy Medicinal Product Market Performance
9.4.4 Sarepta Therapeutics Business Overview
9.4.5 Sarepta Therapeutics Recent Developments
9.5 Alnylam Pharmaceuticals
9.5.1 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Basic Information
9.5.2 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Product Overview
9.5.3 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Product Market Performance
9.5.4 Alnylam Pharmaceuticals Business Overview
9.5.5 Alnylam Pharmaceuticals Recent Developments
9.6 Amgen
9.6.1 Amgen Gene-based Therapy Medicinal Basic Information
9.6.2 Amgen Gene-based Therapy Medicinal Product Overview
9.6.3 Amgen Gene-based Therapy Medicinal Product Market Performance
9.6.4 Amgen Business Overview
9.6.5 Amgen Recent Developments
9.7 Spark Therapeutics
9.7.1 Spark Therapeutics Gene-based Therapy Medicinal Basic Information
9.7.2 Spark Therapeutics Gene-based Therapy Medicinal Product Overview
9.7.3 Spark Therapeutics Gene-based Therapy Medicinal Product Market Performance
9.7.4 Spark Therapeutics Business Overview
9.7.5 Spark Therapeutics Recent Developments
9.8 Akcea Therapeutics
9.8.1 Akcea Therapeutics Gene-based Therapy Medicinal Basic Information
9.8.2 Akcea Therapeutics Gene-based Therapy Medicinal Product Overview
9.8.3 Akcea Therapeutics Gene-based Therapy Medicinal Product Market Performance
9.8.4 Akcea Therapeutics Business Overview
9.8.5 Akcea Therapeutics Recent Developments
9.9 Sunway Biotech
9.9.1 Sunway Biotech Gene-based Therapy Medicinal Basic Information
9.9.2 Sunway Biotech Gene-based Therapy Medicinal Product Overview
9.9.3 Sunway Biotech Gene-based Therapy Medicinal Product Market Performance
9.9.4 Sunway Biotech Business Overview
9.9.5 Sunway Biotech Recent Developments
9.10 SIBIONO
9.10.1 SIBIONO Gene-based Therapy Medicinal Basic Information
9.10.2 SIBIONO Gene-based Therapy Medicinal Product Overview
9.10.3 SIBIONO Gene-based Therapy Medicinal Product Market Performance
9.10.4 SIBIONO Business Overview
9.10.5 SIBIONO Recent Developments
9.11 AnGes
9.11.1 AnGes Gene-based Therapy Medicinal Basic Information
9.11.2 AnGes Gene-based Therapy Medicinal Product Overview
9.11.3 AnGes Gene-based Therapy Medicinal Product Market Performance
9.11.4 AnGes Business Overview
9.11.5 AnGes Recent Developments
9.12 Orchard Therapeutics
9.12.1 Orchard Therapeutics Gene-based Therapy Medicinal Basic Information
9.12.2 Orchard Therapeutics Gene-based Therapy Medicinal Product Overview
9.12.3 Orchard Therapeutics Gene-based Therapy Medicinal Product Market Performance
9.12.4 Orchard Therapeutics Business Overview
9.12.5 Orchard Therapeutics Recent Developments
9.13 Human Stem Cells Institute
9.13.1 Human Stem Cells Institute Gene-based Therapy Medicinal Basic Information
9.13.2 Human Stem Cells Institute Gene-based Therapy Medicinal Product Overview
9.13.3 Human Stem Cells Institute Gene-based Therapy Medicinal Product Market Performance
9.13.4 Human Stem Cells Institute Business Overview
9.13.5 Human Stem Cells Institute Recent Developments
10 GENE-BASED THERAPY MEDICINAL MARKET FORECAST BY REGION
10.1 Global Gene-based Therapy Medicinal Market Size Forecast
10.2 Global Gene-based Therapy Medicinal Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Gene-based Therapy Medicinal Market Size Forecast by Country
10.2.3 Asia Pacific Gene-based Therapy Medicinal Market Size Forecast by Region
10.2.4 South America Gene-based Therapy Medicinal Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Gene-based Therapy Medicinal by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Gene-based Therapy Medicinal Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Gene-based Therapy Medicinal by Type (2025-2030)
11.1.2 Global Gene-based Therapy Medicinal Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Gene-based Therapy Medicinal by Type (2025-2030)
11.2 Global Gene-based Therapy Medicinal Market Forecast by Application (2025-2030)
11.2.1 Global Gene-based Therapy Medicinal Sales (Kilotons) Forecast by Application
11.2.2 Global Gene-based Therapy Medicinal Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gene-based Therapy Medicinal Market Size Comparison by Region (M USD)
Table 5. Global Gene-based Therapy Medicinal Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Gene-based Therapy Medicinal Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Gene-based Therapy Medicinal Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Gene-based Therapy Medicinal Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene-based Therapy Medicinal as of 2022)
Table 10. Global Market Gene-based Therapy Medicinal Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Gene-based Therapy Medicinal Sales Sites and Area Served
Table 12. Manufacturers Gene-based Therapy Medicinal Product Type
Table 13. Global Gene-based Therapy Medicinal Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Gene-based Therapy Medicinal
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gene-based Therapy Medicinal Market Challenges
Table 22. Global Gene-based Therapy Medicinal Sales by Type (Kilotons)
Table 23. Global Gene-based Therapy Medicinal Market Size by Type (M USD)
Table 24. Global Gene-based Therapy Medicinal Sales (Kilotons) by Type (2019-2024)
Table 25. Global Gene-based Therapy Medicinal Sales Market Share by Type (2019-2024)
Table 26. Global Gene-based Therapy Medicinal Market Size (M USD) by Type (2019-2024)
Table 27. Global Gene-based Therapy Medicinal Market Size Share by Type (2019-2024)
Table 28. Global Gene-based Therapy Medicinal Price (USD/Ton) by Type (2019-2024)
Table 29. Global Gene-based Therapy Medicinal Sales (Kilotons) by Application
Table 30. Global Gene-based Therapy Medicinal Market Size by Application
Table 31. Global Gene-based Therapy Medicinal Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Gene-based Therapy Medicinal Sales Market Share by Application (2019-2024)
Table 33. Global Gene-based Therapy Medicinal Sales by Application (2019-2024) & (M USD)
Table 34. Global Gene-based Therapy Medicinal Market Share by Application (2019-2024)
Table 35. Global Gene-based Therapy Medicinal Sales Growth Rate by Application (2019-2024)
Table 36. Global Gene-based Therapy Medicinal Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Gene-based Therapy Medicinal Sales Market Share by Region (2019-2024)
Table 38. North America Gene-based Therapy Medicinal Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Gene-based Therapy Medicinal Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Gene-based Therapy Medicinal Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Gene-based Therapy Medicinal Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Gene-based Therapy Medicinal Sales by Region (2019-2024) & (Kilotons)
Table 43. Biogen Gene-based Therapy Medicinal Basic Information
Table 44. Biogen Gene-based Therapy Medicinal Product Overview
Table 45. Biogen Gene-based Therapy Medicinal Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Biogen Business Overview
Table 47. Biogen Gene-based Therapy Medicinal SWOT Analysis
Table 48. Biogen Recent Developments
Table 49. Novartis Gene-based Therapy Medicinal Basic Information
Table 50. Novartis Gene-based Therapy Medicinal Product Overview
Table 51. Novartis Gene-based Therapy Medicinal Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Novartis Business Overview
Table 53. Novartis Gene-based Therapy Medicinal SWOT Analysis
Table 54. Novartis Recent Developments
Table 55. Gilead Sciences Gene-based Therapy Medicinal Basic Information
Table 56. Gilead Sciences Gene-based Therapy Medicinal Product Overview
Table 57. Gilead Sciences Gene-based Therapy Medicinal Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Gilead Sciences Gene-based Therapy Medicinal SWOT Analysis
Table 59. Gilead Sciences Business Overview
Table 60. Gilead Sciences Recent Developments
Table 61. Sarepta Therapeutics Gene-based Therapy Medicinal Basic Information
Table 62. Sarepta Therapeutics Gene-based Therapy Medicinal Product Overview
Table 63. Sarepta Therapeutics Gene-based Therapy Medicinal Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Sarepta Therapeutics Business Overview
Table 65. Sarepta Therapeutics Recent Developments
Table 66. Alnylam Pharmaceuticals Gene-based Therapy Medicinal Basic Information
Table 67. Alnylam Pharmaceuticals Gene-based Therapy Medicinal Product Overview
Table 68. Alnylam Pharmaceuticals Gene-based Therapy Medicinal Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Alnylam Pharmaceuticals Business Overview
Table 70. Alnylam Pharmaceuticals Recent Developments
Table 71. Amgen Gene-based Therapy Medicinal Basic Information
Table 72. Amgen Gene-based Therapy Medicinal Product Overview
Table 73. Amgen Gene-based Therapy Medicinal Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Amgen Business Overview
Table 75. Amgen Recent Developments
Table 76. Spark Therapeutics Gene-based Therapy Medicinal Basic Information
Table 77. Spark Therapeutics Gene-based Therapy Medicinal Product Overview
Table 78. Spark Therapeutics Gene-based Therapy Medicinal Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Spark Therapeutics Business Overview
Table 80. Spark Therapeutics Recent Developments
Table 81. Akcea Therapeutics Gene-based Therapy Medicinal Basic Information
Table 82. Akcea Therapeutics Gene-based Therapy Medicinal Product Overview
Table 83. Akcea Therapeutics Gene-based Therapy Medicinal Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Akcea Therapeutics Business Overview
Table 85. Akcea Therapeutics Recent Developments
Table 86. Sunway Biotech Gene-based Therapy Medicinal Basic Information
Table 87. Sunway Biotech Gene-based Therapy Medicinal Product Overview
Table 88. Sunway Biotech Gene-based Therapy Medicinal Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Sunway Biotech Business Overview
Table 90. Sunway Biotech Recent Developments
Table 91. SIBIONO Gene-based Therapy Medicinal Basic Information
Table 92. SIBIONO Gene-based Therapy Medicinal Product Overview
Table 93. SIBIONO Gene-based Therapy Medicinal Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. SIBIONO Business Overview
Table 95. SIBIONO Recent Developments
Table 96. AnGes Gene-based Therapy Medicinal Basic Information
Table 97. AnGes Gene-based Therapy Medicinal Product Overview
Table 98. AnGes Gene-based Therapy Medicinal Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. AnGes Business Overview
Table 100. AnGes Recent Developments
Table 101. Orchard Therapeutics Gene-based Therapy Medicinal Basic Information
Table 102. Orchard Therapeutics Gene-based Therapy Medicinal Product Overview
Table 103. Orchard Therapeutics Gene-based Therapy Medicinal Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Orchard Therapeutics Business Overview
Table 105. Orchard Therapeutics Recent Developments
Table 106. Human Stem Cells Institute Gene-based Therapy Medicinal Basic Information
Table 107. Human Stem Cells Institute Gene-based Therapy Medicinal Product Overview
Table 108. Human Stem Cells Institute Gene-based Therapy Medicinal Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Human Stem Cells Institute Business Overview
Table 110. Human Stem Cells Institute Recent Developments
Table 111. Global Gene-based Therapy Medicinal Sales Forecast by Region (2025-2030) & (Kilotons)
Table 112. Global Gene-based Therapy Medicinal Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Gene-based Therapy Medicinal Sales Forecast by Country (2025-2030) & (Kilotons)
Table 114. North America Gene-based Therapy Medicinal Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Gene-based Therapy Medicinal Sales Forecast by Country (2025-2030) & (Kilotons)
Table 116. Europe Gene-based Therapy Medicinal Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Gene-based Therapy Medicinal Sales Forecast by Region (2025-2030) & (Kilotons)
Table 118. Asia Pacific Gene-based Therapy Medicinal Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Gene-based Therapy Medicinal Sales Forecast by Country (2025-2030) & (Kilotons)
Table 120. South America Gene-based Therapy Medicinal Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Gene-based Therapy Medicinal Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Gene-based Therapy Medicinal Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Gene-based Therapy Medicinal Sales Forecast by Type (2025-2030) & (Kilotons)
Table 124. Global Gene-based Therapy Medicinal Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Gene-based Therapy Medicinal Price Forecast by Type (2025-2030) & (USD/Ton)
Table 126. Global Gene-based Therapy Medicinal Sales (Kilotons) Forecast by Application (2025-2030)
Table 127. Global Gene-based Therapy Medicinal Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gene-based Therapy Medicinal Market Size Comparison by Region (M USD)
Table 5. Global Gene-based Therapy Medicinal Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Gene-based Therapy Medicinal Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Gene-based Therapy Medicinal Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Gene-based Therapy Medicinal Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene-based Therapy Medicinal as of 2022)
Table 10. Global Market Gene-based Therapy Medicinal Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Gene-based Therapy Medicinal Sales Sites and Area Served
Table 12. Manufacturers Gene-based Therapy Medicinal Product Type
Table 13. Global Gene-based Therapy Medicinal Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Gene-based Therapy Medicinal
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gene-based Therapy Medicinal Market Challenges
Table 22. Global Gene-based Therapy Medicinal Sales by Type (Kilotons)
Table 23. Global Gene-based Therapy Medicinal Market Size by Type (M USD)
Table 24. Global Gene-based Therapy Medicinal Sales (Kilotons) by Type (2019-2024)
Table 25. Global Gene-based Therapy Medicinal Sales Market Share by Type (2019-2024)
Table 26. Global Gene-based Therapy Medicinal Market Size (M USD) by Type (2019-2024)
Table 27. Global Gene-based Therapy Medicinal Market Size Share by Type (2019-2024)
Table 28. Global Gene-based Therapy Medicinal Price (USD/Ton) by Type (2019-2024)
Table 29. Global Gene-based Therapy Medicinal Sales (Kilotons) by Application
Table 30. Global Gene-based Therapy Medicinal Market Size by Application
Table 31. Global Gene-based Therapy Medicinal Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Gene-based Therapy Medicinal Sales Market Share by Application (2019-2024)
Table 33. Global Gene-based Therapy Medicinal Sales by Application (2019-2024) & (M USD)
Table 34. Global Gene-based Therapy Medicinal Market Share by Application (2019-2024)
Table 35. Global Gene-based Therapy Medicinal Sales Growth Rate by Application (2019-2024)
Table 36. Global Gene-based Therapy Medicinal Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Gene-based Therapy Medicinal Sales Market Share by Region (2019-2024)
Table 38. North America Gene-based Therapy Medicinal Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Gene-based Therapy Medicinal Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Gene-based Therapy Medicinal Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Gene-based Therapy Medicinal Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Gene-based Therapy Medicinal Sales by Region (2019-2024) & (Kilotons)
Table 43. Biogen Gene-based Therapy Medicinal Basic Information
Table 44. Biogen Gene-based Therapy Medicinal Product Overview
Table 45. Biogen Gene-based Therapy Medicinal Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Biogen Business Overview
Table 47. Biogen Gene-based Therapy Medicinal SWOT Analysis
Table 48. Biogen Recent Developments
Table 49. Novartis Gene-based Therapy Medicinal Basic Information
Table 50. Novartis Gene-based Therapy Medicinal Product Overview
Table 51. Novartis Gene-based Therapy Medicinal Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Novartis Business Overview
Table 53. Novartis Gene-based Therapy Medicinal SWOT Analysis
Table 54. Novartis Recent Developments
Table 55. Gilead Sciences Gene-based Therapy Medicinal Basic Information
Table 56. Gilead Sciences Gene-based Therapy Medicinal Product Overview
Table 57. Gilead Sciences Gene-based Therapy Medicinal Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Gilead Sciences Gene-based Therapy Medicinal SWOT Analysis
Table 59. Gilead Sciences Business Overview
Table 60. Gilead Sciences Recent Developments
Table 61. Sarepta Therapeutics Gene-based Therapy Medicinal Basic Information
Table 62. Sarepta Therapeutics Gene-based Therapy Medicinal Product Overview
Table 63. Sarepta Therapeutics Gene-based Therapy Medicinal Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Sarepta Therapeutics Business Overview
Table 65. Sarepta Therapeutics Recent Developments
Table 66. Alnylam Pharmaceuticals Gene-based Therapy Medicinal Basic Information
Table 67. Alnylam Pharmaceuticals Gene-based Therapy Medicinal Product Overview
Table 68. Alnylam Pharmaceuticals Gene-based Therapy Medicinal Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Alnylam Pharmaceuticals Business Overview
Table 70. Alnylam Pharmaceuticals Recent Developments
Table 71. Amgen Gene-based Therapy Medicinal Basic Information
Table 72. Amgen Gene-based Therapy Medicinal Product Overview
Table 73. Amgen Gene-based Therapy Medicinal Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Amgen Business Overview
Table 75. Amgen Recent Developments
Table 76. Spark Therapeutics Gene-based Therapy Medicinal Basic Information
Table 77. Spark Therapeutics Gene-based Therapy Medicinal Product Overview
Table 78. Spark Therapeutics Gene-based Therapy Medicinal Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Spark Therapeutics Business Overview
Table 80. Spark Therapeutics Recent Developments
Table 81. Akcea Therapeutics Gene-based Therapy Medicinal Basic Information
Table 82. Akcea Therapeutics Gene-based Therapy Medicinal Product Overview
Table 83. Akcea Therapeutics Gene-based Therapy Medicinal Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Akcea Therapeutics Business Overview
Table 85. Akcea Therapeutics Recent Developments
Table 86. Sunway Biotech Gene-based Therapy Medicinal Basic Information
Table 87. Sunway Biotech Gene-based Therapy Medicinal Product Overview
Table 88. Sunway Biotech Gene-based Therapy Medicinal Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Sunway Biotech Business Overview
Table 90. Sunway Biotech Recent Developments
Table 91. SIBIONO Gene-based Therapy Medicinal Basic Information
Table 92. SIBIONO Gene-based Therapy Medicinal Product Overview
Table 93. SIBIONO Gene-based Therapy Medicinal Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. SIBIONO Business Overview
Table 95. SIBIONO Recent Developments
Table 96. AnGes Gene-based Therapy Medicinal Basic Information
Table 97. AnGes Gene-based Therapy Medicinal Product Overview
Table 98. AnGes Gene-based Therapy Medicinal Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. AnGes Business Overview
Table 100. AnGes Recent Developments
Table 101. Orchard Therapeutics Gene-based Therapy Medicinal Basic Information
Table 102. Orchard Therapeutics Gene-based Therapy Medicinal Product Overview
Table 103. Orchard Therapeutics Gene-based Therapy Medicinal Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Orchard Therapeutics Business Overview
Table 105. Orchard Therapeutics Recent Developments
Table 106. Human Stem Cells Institute Gene-based Therapy Medicinal Basic Information
Table 107. Human Stem Cells Institute Gene-based Therapy Medicinal Product Overview
Table 108. Human Stem Cells Institute Gene-based Therapy Medicinal Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Human Stem Cells Institute Business Overview
Table 110. Human Stem Cells Institute Recent Developments
Table 111. Global Gene-based Therapy Medicinal Sales Forecast by Region (2025-2030) & (Kilotons)
Table 112. Global Gene-based Therapy Medicinal Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Gene-based Therapy Medicinal Sales Forecast by Country (2025-2030) & (Kilotons)
Table 114. North America Gene-based Therapy Medicinal Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Gene-based Therapy Medicinal Sales Forecast by Country (2025-2030) & (Kilotons)
Table 116. Europe Gene-based Therapy Medicinal Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Gene-based Therapy Medicinal Sales Forecast by Region (2025-2030) & (Kilotons)
Table 118. Asia Pacific Gene-based Therapy Medicinal Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Gene-based Therapy Medicinal Sales Forecast by Country (2025-2030) & (Kilotons)
Table 120. South America Gene-based Therapy Medicinal Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Gene-based Therapy Medicinal Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Gene-based Therapy Medicinal Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Gene-based Therapy Medicinal Sales Forecast by Type (2025-2030) & (Kilotons)
Table 124. Global Gene-based Therapy Medicinal Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Gene-based Therapy Medicinal Price Forecast by Type (2025-2030) & (USD/Ton)
Table 126. Global Gene-based Therapy Medicinal Sales (Kilotons) Forecast by Application (2025-2030)
Table 127. Global Gene-based Therapy Medicinal Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Gene-based Therapy Medicinal
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gene-based Therapy Medicinal Market Size (M USD), 2019-2030
Figure 5. Global Gene-based Therapy Medicinal Market Size (M USD) (2019-2030)
Figure 6. Global Gene-based Therapy Medicinal Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gene-based Therapy Medicinal Market Size by Country (M USD)
Figure 11. Gene-based Therapy Medicinal Sales Share by Manufacturers in 2023
Figure 12. Global Gene-based Therapy Medicinal Revenue Share by Manufacturers in 2023
Figure 13. Gene-based Therapy Medicinal Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Gene-based Therapy Medicinal Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Gene-based Therapy Medicinal Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Gene-based Therapy Medicinal Market Share by Type
Figure 18. Sales Market Share of Gene-based Therapy Medicinal by Type (2019-2024)
Figure 19. Sales Market Share of Gene-based Therapy Medicinal by Type in 2023
Figure 20. Market Size Share of Gene-based Therapy Medicinal by Type (2019-2024)
Figure 21. Market Size Market Share of Gene-based Therapy Medicinal by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Gene-based Therapy Medicinal Market Share by Application
Figure 24. Global Gene-based Therapy Medicinal Sales Market Share by Application (2019-2024)
Figure 25. Global Gene-based Therapy Medicinal Sales Market Share by Application in 2023
Figure 26. Global Gene-based Therapy Medicinal Market Share by Application (2019-2024)
Figure 27. Global Gene-based Therapy Medicinal Market Share by Application in 2023
Figure 28. Global Gene-based Therapy Medicinal Sales Growth Rate by Application (2019-2024)
Figure 29. Global Gene-based Therapy Medicinal Sales Market Share by Region (2019-2024)
Figure 30. North America Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Gene-based Therapy Medicinal Sales Market Share by Country in 2023
Figure 32. U.S. Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Gene-based Therapy Medicinal Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Gene-based Therapy Medicinal Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Gene-based Therapy Medicinal Sales Market Share by Country in 2023
Figure 37. Germany Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Gene-based Therapy Medicinal Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Gene-based Therapy Medicinal Sales Market Share by Region in 2023
Figure 44. China Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Gene-based Therapy Medicinal Sales and Growth Rate (Kilotons)
Figure 50. South America Gene-based Therapy Medicinal Sales Market Share by Country in 2023
Figure 51. Brazil Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Gene-based Therapy Medicinal Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Gene-based Therapy Medicinal Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Gene-based Therapy Medicinal Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Gene-based Therapy Medicinal Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Gene-based Therapy Medicinal Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Gene-based Therapy Medicinal Market Share Forecast by Type (2025-2030)
Figure 65. Global Gene-based Therapy Medicinal Sales Forecast by Application (2025-2030)
Figure 66. Global Gene-based Therapy Medicinal Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Gene-based Therapy Medicinal
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gene-based Therapy Medicinal Market Size (M USD), 2019-2030
Figure 5. Global Gene-based Therapy Medicinal Market Size (M USD) (2019-2030)
Figure 6. Global Gene-based Therapy Medicinal Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gene-based Therapy Medicinal Market Size by Country (M USD)
Figure 11. Gene-based Therapy Medicinal Sales Share by Manufacturers in 2023
Figure 12. Global Gene-based Therapy Medicinal Revenue Share by Manufacturers in 2023
Figure 13. Gene-based Therapy Medicinal Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Gene-based Therapy Medicinal Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Gene-based Therapy Medicinal Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Gene-based Therapy Medicinal Market Share by Type
Figure 18. Sales Market Share of Gene-based Therapy Medicinal by Type (2019-2024)
Figure 19. Sales Market Share of Gene-based Therapy Medicinal by Type in 2023
Figure 20. Market Size Share of Gene-based Therapy Medicinal by Type (2019-2024)
Figure 21. Market Size Market Share of Gene-based Therapy Medicinal by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Gene-based Therapy Medicinal Market Share by Application
Figure 24. Global Gene-based Therapy Medicinal Sales Market Share by Application (2019-2024)
Figure 25. Global Gene-based Therapy Medicinal Sales Market Share by Application in 2023
Figure 26. Global Gene-based Therapy Medicinal Market Share by Application (2019-2024)
Figure 27. Global Gene-based Therapy Medicinal Market Share by Application in 2023
Figure 28. Global Gene-based Therapy Medicinal Sales Growth Rate by Application (2019-2024)
Figure 29. Global Gene-based Therapy Medicinal Sales Market Share by Region (2019-2024)
Figure 30. North America Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Gene-based Therapy Medicinal Sales Market Share by Country in 2023
Figure 32. U.S. Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Gene-based Therapy Medicinal Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Gene-based Therapy Medicinal Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Gene-based Therapy Medicinal Sales Market Share by Country in 2023
Figure 37. Germany Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Gene-based Therapy Medicinal Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Gene-based Therapy Medicinal Sales Market Share by Region in 2023
Figure 44. China Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Gene-based Therapy Medicinal Sales and Growth Rate (Kilotons)
Figure 50. South America Gene-based Therapy Medicinal Sales Market Share by Country in 2023
Figure 51. Brazil Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Gene-based Therapy Medicinal Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Gene-based Therapy Medicinal Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Gene-based Therapy Medicinal Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Gene-based Therapy Medicinal Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Gene-based Therapy Medicinal Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Gene-based Therapy Medicinal Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Gene-based Therapy Medicinal Market Share Forecast by Type (2025-2030)
Figure 65. Global Gene-based Therapy Medicinal Sales Forecast by Application (2025-2030)
Figure 66. Global Gene-based Therapy Medicinal Market Share Forecast by Application (2025-2030)
